Berman JJ, Albores-Saavedra J, Bostwick D et al (2006) Precancer: a conceptual working definition -- results of a Consensus Conference. Cancer Detect Prev 30(5):387–394. https://doi.org/10.1016/j.cdp.2006.09.002
Klimstra DS, Hruban RH, Siegel CS, Klöppel G (2023) Tumors of the pancreas, 5 edn. American Registry of Pathology, Arlington, VA
Ma H, Brosens LAA, Offerhaus GJA, Giardiello FM, de Leng WWJ, Montgomery EA (2018) Pathology and genetics of hereditary colorectal cancer. Pathology 50(1):49–59. https://doi.org/10.1016/j.pathol.2017.09.004
Article CAS PubMed Google Scholar
Kinzler KW, Vogelstein B (1997) Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386(6627):761–763. https://doi.org/10.1038/386761a0
Article CAS PubMed Google Scholar
Rosty C (2018) The role of the Surgical pathologist in the diagnosis of gastrointestinal polyposis syndromes. Adv Anat Pathol 25(1):1–13. https://doi.org/10.1097/PAP.0000000000000173
Olkinuora AP, Peltomaki PT, Aaltonen LA, Rajamaki K (2021) From APC to the genetics of hereditary and familial colon cancer syndromes. Hum Mol Genet 30(R2):R206–R24. https://doi.org/10.1093/hmg/ddab208
Article CAS PubMed PubMed Central Google Scholar
Helderman NC, Van Der Werf-‘t Lam AS et al (2023) Msh6 Tumor G,. Molecular Profile of MSH6-Associated Colorectal Carcinomas Shows Distinct Features From Other Lynch Syndrome-Associated Colorectal Carcinomas. Gastroenterology 165(1): 271-4 e2 https://doi.org/10.1053/j.gastro.2023.03.198
Helderman NC, Bajwa-Ten Broeke SW, Morreau H et al (2021) The diverse molecular profiles of lynch syndrome-associated colorectal cancers are (highly) dependent on underlying germline mismatch repair mutations. Crit Rev Oncol Hematol 163:103338. https://doi.org/10.1016/j.critrevonc.2021.103338
Valle L (2023) Lynch Syndrome: a single Hereditary Cancer Syndrome or multiple syndromes defined by different mismatch. Repair Genes? Gastroenterology 165(1):20–23. https://doi.org/10.1053/j.gastro.2023.04.027
Article CAS PubMed Google Scholar
Hsu FC, Roberts NJ, Childs E et al (2021) Risk of pancreatic Cancer among individuals with pathogenic variants in the ATM Gene. JAMA Oncol 7(11):1664–1668. https://doi.org/10.1001/jamaoncol.2021.3701
Roberts NJ, Jiao Y, Yu J et al (2012) ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov 2(1): 41 – 6 https://doi.org/10.1158/2159-8290.CD-11-0194
Roberts NJ, Norris AL, Petersen GM et al (2016) Whole genome sequencing defines the genetic heterogeneity of familial pancreatic Cancer. Cancer Discov 6(2):166–175. https://doi.org/10.1158/2159-8290.CD-15-0402
Article CAS PubMed Google Scholar
Zhen DB, Rabe KG, Gallinger S et al (2015) BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genet Med 17(7):569–577. https://doi.org/10.1038/gim.2014.153
Article CAS PubMed Google Scholar
Grover S, Syngal S (2010) Hereditary pancreatic cancer. Gastroenterology 139(4): 1076-80, 80 e1-2 https://doi.org/10.1053/j.gastro.2010.08.012
Porter N, Laheru D, Lau B et al (2022) Risk of pancreatic Cancer in the long-term prospective Follow-Up of familial pancreatic Cancer kindreds. J Natl Cancer Inst 114(12):1681–1688. https://doi.org/10.1093/jnci/djac167
Article PubMed PubMed Central Google Scholar
Shindo K, Yu J, Suenaga M et al (2017) Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma. J Clin Oncol 35(30):3382–3390. https://doi.org/10.1200/JCO.2017.72.3502
Article CAS PubMed PubMed Central Google Scholar
Hata T, Suenaga M, Marchionni L et al (2018) Genome-wide somatic Copy number alterations and mutations in high-Grade Pancreatic Intraepithelial Neoplasia. Am J Pathol 188(7):1723–1733. https://doi.org/10.1016/j.ajpath.2018.03.012
Article CAS PubMed PubMed Central Google Scholar
Basturk O, Hong SM, Wood LD et al (2015) A revised classification system and recommendations from the Baltimore Consensus Meeting for neoplastic precursor lesions in the pancreas. Am J Surg Pathol 39(12):1730–1741. https://doi.org/10.1097/PAS.0000000000000533
Article PubMed PubMed Central Google Scholar
Assarzadegan N, Thompson E, Salimian K et al (2021) Pathology of intraductal papillary mucinous neoplasms. Langenbecks Arch Surg 406(8):2643–2655. https://doi.org/10.1007/s00423-021-02201-0
Article PubMed PubMed Central Google Scholar
Basturk O, Adsay V, Askan G et al (2017) Intraductal Tubulopapillary Neoplasm of the pancreas: a clinicopathologic and immunohistochemical analysis of 33 cases. Am J Surg Pathol 41(3):313–325. https://doi.org/10.1097/PAS.0000000000000782
Article PubMed PubMed Central Google Scholar
Andea A, Sarkar F, Adsay VN (2003) Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Mod Pathol 16(10):996–1006. https://doi.org/10.1097/01.MP.0000087422.24733.62
Detlefsen S, Sipos B, Feyerabend B, Klöppel G (2005) Pancreatic fibrosis associated with age and ductal papillary hyperplasia. Virchows Arch 447(5):800–805. https://doi.org/10.1007/s00428-005-0032-1
Hiraoka N, Onozato K, Kosuge T, Hirohashi S (2006) Prevalence of FOXP3 + regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 12(18):5423–5434. https://doi.org/10.1158/1078-0432.CCR-06-0369
Article CAS PubMed Google Scholar
Pollini T, Adsay V, Capurso G et al (2022) The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms. Lancet Gastroenterol Hepatol 7(12):1141–1150. https://doi.org/10.1016/S2468-1253(22)00235-7
Article PubMed PubMed Central Google Scholar
Pancreas ESGCT (2018) European evidence-based guidelines on pancreatic cystic neoplasms. Gut 67(5):789–804. https://doi.org/10.1136/gutjnl-2018-316027
Kromrey ML, Bulow R, Hubner J et al (2018) Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study. Gut 67(1):138–145. https://doi.org/10.1136/gutjnl-2016-313127
Laffan TA, Horton KM, Klein AP et al (2008) Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol 191(3):802–807. https://doi.org/10.2214/AJR.07.3340
Article PubMed PubMed Central Google Scholar
Aichler M, Seiler C, Tost M et al (2012) Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues. J Pathol 226(5):723–734. https://doi.org/10.1002/path.3017
Article CAS PubMed Google Scholar
Singhi AD, Wood LD, Parks E et al (2020) Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct. Gastroenterology 158(3): 573 – 82 e2 https://doi.org/10.1053/j.gastro.2019.10.028
Lee JW, Hruban RH, Brosens LAA et al (2023) RNA sequencing identifies frequent mitogen-activated protein kinase-associated Fusion genes in Intraductal Tubulopapillary neoplasms of the pancreas. Gastroenterology 164(7):1310–1313. https://doi.org/10.1053/j.gastro.2023.02.006
Article CAS PubMed Google Scholar
Rabe KG, Stevens MA, Hernandez AT et al (2022) Pancreatic cancer risk to siblings of probands in bilineal cancer settings. Genet Med 24(5):1008–1016. https://doi.org/10.1016/j.gim.2022.01.016
Article CAS PubMed PubMed Central Google Scholar
Singhi AD, Ishida H, Ali SZ et al (2015) A histomorphologic comparison of familial and sporadic pancreatic cancers. Pancreatology 15(4):387–391. https://doi.org/10.1016/j.pan.2015.04.003
Comments (0)